Afyren SAS risk profile
82 Acute at or past the historical limit
Measured 1 September 2026 from ALAFY's filed statements. Recomputed nightly.
82 (Acute), driven by Cash conversion at 100, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 56 | Elevated | Volatile | One-year price volatility — 55.4% |
| Operating pressure | 93 | Acute | Stable | Costs outgrowing revenue — +25.9 percentage points |
| Cash conversion | 100 | Acute | Stable | Capital spending against operating cash — -0.03x |
| Leverage and coverage | 35 | Normal | Stable | Interest cover — -179.11x |
| Competitive position | 92 | Acute | Stable | Operating-margin gap against peers — -315.9 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.